XML 31 R110.htm IDEA: XBRL DOCUMENT v3.20.1
Parent Company Only (Schedule of Condensed Cash Flow Statement) (Details) - USD ($)
$ in Thousands
3 Months Ended 12 Months Ended
Dec. 31, 2019
Sep. 30, 2019
Jun. 30, 2019
Mar. 31, 2019
Dec. 31, 2018
Sep. 30, 2018
Jun. 30, 2018
Mar. 31, 2018
Dec. 31, 2017
Sep. 30, 2017
Jun. 30, 2017
Mar. 31, 2017
Dec. 31, 2019
Dec. 31, 2018
Dec. 31, 2017
Condensed Financial Statements, Captions [Line Items]                              
Net income $ 2,714 $ 3,058 $ 3,002 $ 2,802 $ 2,847 $ 2,863 $ 2,768 $ 2,528 $ 2,327 $ 2,226 $ 2,183 $ 1,980 $ 11,576 $ 11,006 $ 8,716
Stock-based compensation expense                         817 749 550
Deferred income tax expense                         341 1,019 (666)
Gain on sale of investment securities                           (44)  
Net cash provided by operating activities                         25,786 13,650 13,887
Proceeds from sales of investment securities                         10,952 13,514 5,970
Net cash used in investing activities                         (33,996) (117,119) (69,842)
Exercise of stock options                           14 416
Withholdings to purchase capital stock                         175 149 126
Cash paid in lieu of fractional shares                             (11)
Net cash provided by financing activities                         6,388 105,129 45,937
Net (decrease) increase in cash and cash equivalents                         (1,822) 1,660 (10,018)
Cash and cash equivalents, beginning       17,485       15,825       25,843 17,485 15,825 25,843
Cash and cash equivalents, ending 15,663       17,485       15,825       15,663 17,485 15,825
Parent Company [Member]                              
Condensed Financial Statements, Captions [Line Items]                              
Net income                         11,576 11,006 8,716
Equity in earnings of subsidiary                         (12,876) (11,996) (9,258)
Stock-based compensation expense                         817 749 550
Deferred income tax expense                         2 (60) (69)
Gain on sale of investment securities                           (44)  
Changes in other assets and liabilities, net                         137 12 (26)
Net cash provided by operating activities                         (344) (333) (87)
Dividends received from subsidiary                         4,037 2,723 2,574
Proceeds from sales of investment securities                           871  
Net cash used in investing activities                         4,037 3,594 2,574
Dividends paid, net of dividends reinvested                         (4,037) (3,397) (2,954)
Exercise of stock options                           14 416
Withholdings to purchase capital stock                         175 149 126
Cash paid in lieu of fractional shares                             (11)
Net cash provided by financing activities                         (3,862) (3,234) (2,423)
Net (decrease) increase in cash and cash equivalents                         (169) 27 64
Cash and cash equivalents, beginning       $ 232       $ 205       $ 141 232 205 141
Cash and cash equivalents, ending $ 63       $ 232       $ 205       $ 63 $ 232 $ 205